Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Arthritis, Rheumatoid × Radioimmunodetection × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Spondylarthritis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Burkitt Lymphoma 1 Arthritis, Rheumatoid 1

Interventions

Methotrexate 4 Abatacept 3 tocilizumab 2 Rituximab 2 tofacitinib 1 secukinumab 1 olokizumab 1 golimumab 1 baricitinib 1 Radioimmunodetection 1 RC-18 1 Etanercept 1 Double-Blind Method 1 Certolizumab Pegol 1 Antirheumatic Agents 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01590966 2019-08-26

SCINTRA

University Hospital, Ghent

Phase 3 Completed

Arthritis, Rheumatoid, Spondylarthritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡